ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy (OPTILIV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00852228
Recruitment Status : Unknown
Verified December 2013 by Association pour la Recherche sur le Temps Biologique et la Chronothérapie.
Recruitment status was:  Active, not recruiting
First Posted : February 26, 2009
Last Update Posted : December 12, 2013
Sponsor:
Collaborators:
Gustave Roussy, Cancer Campus, Grand Paris
Merck Serono International SA
Pfizer
CRESGE
Information provided by (Responsible Party):
Association pour la Recherche sur le Temps Biologique et la Chronothérapie